BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26625745)

  • 21. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
    Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
    Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival outcomes and patterns of failure in women with stage IIIC
    Lee JK; Mahan M; Hanna RK; Elshaikh MA
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
    Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
    Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring System.
    Bendifallah S; Canlorbe G; Arsène E; Collinet P; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Daraï E; Ballester M
    Ann Surg Oncol; 2015 Aug; 22(8):2722-8. PubMed ID: 25564162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
    Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
    Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
    Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
    BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study.
    Bendifallah S; Canlorbe G; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Bleu G; Daraï E; Ballester M
    Ann Surg Oncol; 2014 Dec; 21(13):4239-45. PubMed ID: 24969441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of patients with stage IIIC endometrial cancer.
    Turan T; Ureyen I; Duzguner I; Ozkaya E; Tasci T; Karalok A; Boran N; Kose MF; Tulunay G
    Int J Gynecol Cancer; 2014 Jul; 24(6):1033-41. PubMed ID: 24905617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial cancer: predictors of peritoneal failure.
    Mariani A; Webb MJ; Keeney GL; Aletti G; Podratz KC
    Gynecol Oncol; 2003 May; 89(2):236-42. PubMed ID: 12713986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of tumor grade on survival end points and patterns of recurrence of 949 patients with early-stage endometrioid carcinoma: a single institution study.
    Gayar OH; Patel S; Schultz D; Mahan M; Rasool N; Elshaikh MA
    Int J Gynecol Cancer; 2014 Jan; 24(1):97-101. PubMed ID: 24264358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion.
    Mahdi H; Jernigan A; Nutter B; Michener C; Rose PG
    J Gynecol Oncol; 2015 Jul; 26(3):208-13. PubMed ID: 25686395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma.
    Roma AA; Rybicki LA; Barbuto D; Euscher E; Djordjevic B; Frauenhoffer E; Kim I; Hong SR; Montiel D; Ali-Fehmi R; Malpica A; Silva EG
    Hum Pathol; 2015 Oct; 46(10):1529-39. PubMed ID: 26264257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer.
    Lum MM; Belnap TW; Frandsen J; Brown AP; Sause WT; Soisson AP; Dodson MK; Werner T; Gaffney DK
    Am J Clin Oncol; 2015 Jun; 38(3):283-8. PubMed ID: 23774072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study.
    Semaan A; Mert I; Munkarah AR; Bandyopadhyay S; Mahdi HS; Winer IS; Nucci MR; Hussein Y; Quershi F; Hayek K; Tabassum F; Alosh B; Schultz DS; Cote ML; Vijver KK; Morris RT; Oliva E; Ali-Fehmi R
    Int J Gynecol Pathol; 2013 Mar; 32(2):181-7. PubMed ID: 23370657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of Lymph Node Metastasis in Surgically Staged FIGO IA G1/G2 Endometrial Cancer With a Tumor Size of More Than 2 cm.
    Boyraz G; Salman MC; Gultekin M; Basaran D; Cagan M; Ozgul N; Yuce K
    Int J Gynecol Cancer; 2017 Mar; 27(3):486-492. PubMed ID: 28187095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.